🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thomas Jaki

ORCID: 0000-0002-1096-188X

Also affiliated with University of Cambridge, MRC Biostatistics Unit, University of Regensburg

MathematicsDecision SciencesEconomics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 10 papers. Top paper: “Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial”.

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

The Lancet(2020)10.1016/s0140-6736(20)31022-9

N/A

11.3DataRank · unranked

3663 citations

Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin +41 more

Dexamethasone in Hospitalized Patients with Covid-19.

DiRROS repository (University of Maribor)(2020)10.17863/cam.57006

N/A

1.3DataRank · unranked

8045 citations

Juan José Montoya, Jonathan Emberson, Marion Mafham, Jennifer Bell, Louise Linsell +22 more

Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials

PLOS ONE(2016)10.1371/journal.pone.0146465

N/A

0.578DataRank · unranked

46 citations

Thomas Jaki, Franz Koenig, Martin Posch, Dominic Magirr

Individual differences in the effects of the ACTION-PAC intervention: an application of personalized medicine in the prevention and treatment of obesity

Journal of Behavioral Medicine(2022)10.1007/s10865-021-00274-2

N/A

0.312DataRank · unranked

7 citations

Thomas Jaki, Elizabeth Yakes Jimenez, Alberta S. Kong, Hope A. Gill, Chi Chang +4 more

An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS-CoV-2

medRxiv(2021)10.1101/2021.09.10.21263376

N/A

0DataRank · unranked

0 citations

Richard J. Fitzgerald, Geoffrey Saunders, Rebecca Lyon, Michael Fisher, Karen Martin +27 more

Applying methods for personalized medicine to the treatment of alcohol use disorder.

Journal of Consulting and Clinical Psychology(2021)10.1037/ccp0000634

N/A

0DataRank · unranked

30 citations

Yasin Desai, Alexandra Tonigan, Katie Witkiewitz, Thomas Jaki, Yu‐Yu Hsiao +3 more

Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study

BMC Medicine(2023)10.1186/s12916-023-02937-0

N/A

0DataRank · unranked

12 citations

Munyaradzi Dimairo, Christopher J. Weir, Siew Wan Hee, Aude Espinasse, Moreno Ursino +18 more

Development process of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE (DosE FIndiNg Extensions) study

MetArXiv (OSF Preprints)(2023)10.31222/osf.io/jtpz2

N/A

0DataRank · unranked

0 citations

Munyaradzi Dimairo, Christopher J. Weir, Siew Wan Hee, Moreno Ursino, Aude Espinasse +18 more

Endpoints for randomized controlled clinical trials for COVID-19 treatments

Clinical Trials(2020)10.1177/1740774520939938

N/A

0DataRank · unranked

4 citations

Dean Follmann, Jing Wang, Franz Koenig, Lisa L. Korn, Christian Schoergenhofer +10 more

SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol

BMJ Open(2023)10.1136/bmjopen-2022-068173

N/A

0DataRank · unranked

33 citations

Olga Solovyeva, Munyaradzi Dimairo, Christopher J. Weir, Thomas Jaki, Adrian Mander +11 more